Pacira Biosciences, Inc. (PCRX)
36.34
+0.04
(+0.10%)
USD |
NASDAQ |
Oct 12, 16:00
36.34
0.00 (0.00%)
After-Hours: 17:14
Pacira Biosciences Net Income (TTM) : 14.64M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.64M |
| March 31, 2026 | 5.138M |
| December 31, 2025 | 7.034M |
| September 30, 2025 | 21.44M |
| June 30, 2025 | -127.46M |
| March 31, 2025 | -103.73M |
| December 31, 2024 | -99.56M |
| September 30, 2024 | -90.73M |
| June 30, 2024 | 63.59M |
| March 31, 2024 | 70.47M |
| December 31, 2023 | 41.96M |
| September 30, 2023 | 6.983M |
| June 30, 2023 | -4.568M |
| March 31, 2023 | -10.46M |
| December 31, 2022 | 15.91M |
| September 30, 2022 | 20.88M |
| June 30, 2022 | 39.24M |
| March 31, 2022 | 38.44M |
| December 31, 2021 | 41.98M |
| September 30, 2021 | 61.62M |
| June 30, 2021 | 174.08M |
| March 31, 2021 | 147.73M |
| December 31, 2020 | 145.52M |
| September 30, 2020 | 126.12M |
| June 30, 2020 | -10.08M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.086M |
| December 31, 2019 | -11.02M |
| September 30, 2019 | 2.157M |
| June 30, 2019 | 7.604M |
| March 31, 2019 | 7.438M |
| December 31, 2018 | -0.471M |
| September 30, 2018 | -4.161M |
| June 30, 2018 | -11.12M |
| March 31, 2018 | -33.42M |
| December 31, 2017 | -42.61M |
| September 30, 2017 | -51.18M |
| June 30, 2017 | -65.75M |
| March 31, 2017 | -53.96M |
| December 31, 2016 | -37.95M |
| September 30, 2016 | -36.47M |
| June 30, 2016 | -11.22M |
| March 31, 2016 | -3.258M |
| December 31, 2015 | 1.856M |
| September 30, 2015 | 10.16M |
| June 30, 2015 | 4.066M |
| March 31, 2015 | -0.979M |
| December 31, 2014 | -13.72M |
| September 30, 2014 | -31.47M |
| June 30, 2014 | -43.25M |
| March 31, 2014 | -52.25M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Viatris, Inc. | -410.70M |
| Johnson & Johnson | 21.04B |
| Liquidia Corp. | 138.61M |
| Organon & Co. | 209.00M |
| ANI Pharmaceuticals, Inc. | 99.95M |